, Tracking Stock Market Picks
Enter Symbol:
Valeant Pharmaceuticals International Inc (VRX) [hlAlert]

up 1,154.80 %

Valeant Pharmaceuticals International Inc (VRX) rated Outperform with price target $51 by RBC Capital Mkts

Posted on: Thursday,  May 5, 2011  11:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Valeant Pharmaceuticals International Inc (NYSE: VRX) on 05/05/2011. Previously RBC Capital Mkts rated Buy Valeant Pharmaceuticals International Inc (NYSE:
VRX) on 10/25/2007., when the stock price was $18.72. Since then, Valeant Pharmaceuticals International Inc has gained 1154.81% as of 01/06/2016's recent price of $234.90.
If you would have followed the previous RBC Capital Mkts's recommendation on VRX, you would have gained 1154.8% of your investment in 2995 days.

Biovail Corporation (Biovail) is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The Company has various research and development, clinical research, manufacturing and commercial operations located in Barbados, Canada, the United States and Puerto Rico. Its main therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease. The primary markets for its products are the United States and Canada. On September 16, 2008, Biovail acquired Prestwick Pharmaceuticals, Inc.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/5/2011 11:25 AM Buy
48.92 51.00
as of 12/30/2011
1 Week up  7.22 %
1 Month up  32.43 %
3 Months up  143.10 %
1 YTD up  234.88 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/8/2010 9:25 AM Buy
26.59 34.00
6/22/2010 9:25 AM Buy
16.59 21.00
1/20/2010 9:25 AM Buy
15.68 17.00
8/11/2008 8:25 AM Buy
9.97 13.00
2/6/2008 9:25 AM Buy
13.63 17.00
10/25/2007 9:25 AM Buy
18.72 24.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy